欢迎访问ProbeChem中文网站,英文网站请访问www.probechem.com

首页-小分子抑制剂&激动剂-Proteasome/Ubiquitin-E3 Ubiquitin Ligase-Tasisulam sodium
Tasisulam sodium

Chemical Structure : Tasisulam sodium

CAS No.: 519055-63-1

Tasisulam sodium (LY 573636 sodium)

货号: PC-62312Not For Human Use, Lab Use Only.

Tasisulam (LY 573636) is a small molecule antitumor agent that induces apoptosis via the intrinsic pathway, resulting in cytochrome c release and caspase-dependent cell death.

规格 价格 库存 数量
25 mg Get quote
100 mg Get quote
200 mg Get quote
1 g Get quote

大包装,大折扣!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

纯度 & COA & 质检文件 纯度: >98% (HPLC) Select Batch:

生物&药学活性

Tasisulam sodium (LY-573636) is a small molecule antitumor agent that induces apoptosis via the intrinsic pathway, resulting in cytochrome c release and caspase-dependent cell death.
Tasisulam sodium shows antiproliferative effect against a variety of human hematopoietic malignancies, including AML, B-ALL, large B-cell and mantle cell lymphoma cell lines.
Tasisulam sodium promotes the recruitment of RBM39 to the CUL4-DCAF15 E3 ubiquitin ligase, leading to RBM39 polyubiquitination and proteasomal degradation.
Tasisulam sodium causes aberrant pre-mRNA splicing.

物理化学性质&存储条件

分子量 437.09
分子式 C11H5BrCl2NNaO3S2
外观性状 Solid
CAS No.
储存条件
固体粉末
-20 °C 12 个月; 4°C 6 个月
配置液
-80 °C 6 个月; -20°C 6 个月
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

N-[(5-bromo-2-thienyl)sulfonyl]-2,4-dichloro-benzamide sodium salt

参考文献

1. Meier T, et al. Mol Cancer Ther. 2011 Nov;10(11):2168-78.

2. Haritunians T, et al. Oncol Rep. 2008 Nov;20(5):1237-42.

3. Han T, et al. Science. 2017 Apr 28;356(6336). pii: eaal3755.

备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

联系我们 sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

询单

  • *产品名称:
  • *姓名:
  • *邮箱:
  • *公司名称:
  • *询单数量:
  • *国籍:
  • 询单信息: